Literature DB >> 21118105

The neuronal ceroid lipofuscinoses: the same, but different?

Jonathan D Cooper1.   

Abstract

The NCLs (neuronal ceroid lipofuscinoses) (also known as Batten disease) are a group of at least ten fatal inherited storage disorders. Despite the identification of many of the disease-causing genes, very little is known about the underlying disease mechanisms. However, now that we have mouse or large-animal models for most forms of NCL, we can investigate pathogenesis and compare what happens in the brain in different types of the disease. Broadly similar neuropathological themes have emerged, including the highly selective nature of neuron loss, early effects upon the presynaptic compartment, together with an early and localized glial activation. These events are especially pronounced within the thalamocortical system, but it is clear that where and when they occur varies markedly between different forms of NCL. It is now becoming apparent that, despite having pathological endpoints that resemble one another, these are reached by a sequence of events that is specific to each subtype of NCL.

Entities:  

Mesh:

Year:  2010        PMID: 21118105     DOI: 10.1042/BST0381448

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  14 in total

1.  A Case-controlled Investigation of Pain Experience and Sensory Function in Neuronal Ceroid Lipofuscinosis.

Authors:  Chantel C Barney; John Hoch; Breanne Byiers; Adele Dimian; Frank J Symons
Journal:  Clin J Pain       Date:  2015-11       Impact factor: 3.442

2.  A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.

Authors:  John F Staropoli; Amel Karaa; Elaine T Lim; Andrew Kirby; Naser Elbalalesy; Stephen G Romansky; Karen B Leydiker; Scott H Coppel; Rosemary Barone; Winnie Xin; Marcy E MacDonald; Jose E Abdenur; Mark J Daly; Katherine B Sims; Susan L Cotman
Journal:  Am J Hum Genet       Date:  2012-06-28       Impact factor: 11.025

3.  Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.

Authors:  Jonathan B Rosenberg; Alvin Chen; Stephen M Kaminsky; Ronald G Crystal; Dolan Sondhi
Journal:  Expert Opin Orphan Drugs       Date:  2019-11-27       Impact factor: 0.694

4.  Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis.

Authors:  Melanie Thelen; Markus Damme; Markus Daμμe; Michaela Schweizer; Christian Hagel; Andrew M S Wong; Jonathan D Cooper; Thomas Braulke; Giovanna Galliciotti
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

5.  Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice.

Authors:  Yoshinori Tanaka; James K Chambers; Takashi Matsuwaki; Keitaro Yamanouchi; Masugi Nishihara
Journal:  Acta Neuropathol Commun       Date:  2014-07-15       Impact factor: 7.801

6.  A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.

Authors:  Juyuan Guo; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Natasha J Olby; Jeremy F Taylor; Robert D Schnabel; Martin L Katz; Gary S Johnson
Journal:  BMC Vet Res       Date:  2015-01-03       Impact factor: 2.741

7.  Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice.

Authors:  Tea Blom; Mia-Lisa Schmiedt; Andrew M Wong; Aija Kyttälä; Jarkko Soronen; Matti Jauhiainen; Jaana Tyynelä; Jonathan D Cooper; Anu Jalanko
Journal:  Dis Model Mech       Date:  2012-10-12       Impact factor: 5.758

8.  Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression.

Authors:  Graham W Kay; David N Palmer
Journal:  J Neuroinflammation       Date:  2013-07-30       Impact factor: 8.322

9.  A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.

Authors:  Jeremy P Morgan; Helen Magee; Andrew Wong; Tarah Nelson; Bettina Koch; Jonathan D Cooper; Jill M Weimer
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

10.  Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography.

Authors:  Janos Groh; David Stadler; Mathias Buttmann; Rudolf Martini
Journal:  Acta Neuropathol Commun       Date:  2014-05-10       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.